Key Points
- To determine the cellular composition and phenotypic characteristics of fibrocellular tissue causing restenosis after percutaneous transluminal coronary angioplasty (PTCA) in human coronary arteries.
- Examined 5 coronary arteries from 4 human hearts obtained postmortem, with intervals between PTCA and death ranging from 20 days (2 arteries) to 1 year 7 months.
- Performed immunocytochemical analysis using smooth muscle cell-specific monoclonal antibodies, vimentin, and desmin to characterize cellular phenotypes across different lesion ages.
- Proliferating cells in post-PTCA lesions stained positive for smooth muscle cell-specific antibodies and vimentin, but negative for desmin, regardless of lesion age.
- Smooth muscle cells in early proliferative lesions (20 days post-PTCA) displayed a distinct phenotypic expression compared to cells in older lesions, demonstrating dynamic alterations in actin isoform expression during pathological adaptation.
Structured PICO
PPopulation4 human hearts (5 coronary arteries) from patients who died after initial successful percutaneous transluminal coronary angioplasty (PTCA)
IInterventionImmunocytochemical analysis of fibrocellular tissue
OOutcomeCellular composition and phenotypic expression of fibrocellular tissuesurrogate
Restenosis after PTCA involves smooth muscle cell proliferation with changes in actin isoform expression as they adapt to a pathological state.